Transplants

A New Zealand bio-tech company is trumpeting a major breakthrough after a diabetic given a trial transplant of pig cells was able to stop her insulin injections.

Merck & Co., announced that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for JANUVIA(TM) (sitagliptin), the only DPP-4 inhibitor available in the United States for the treatment of type 2 diabetes.

With an eye on curing diabetes, scientists at Washington University School of Medicine in St. Louis have successfully transplanted embryonic pig pancreatic cells destined to produce insulin into diabetic macaque monkeys — all without the need for risky immune suppression drugs that prevent rejection.

A simple imaging technique has revealed fat buildup in the hearts of pre-diabetic people long before symptoms of heart disease or diabetes appear.

A new drug therapy for three months is showing great promise in returning patients with type 1 diabetes to insulin independence.

Researchers at Johns Hopkins have found a way to overcome a major stumbling block to developing successful insulin-cell transplants for people with type I diabetes.

Dr. Sheri Colberg, author of The 7 Step Diabetes Fitness Plan: Living Well and Being Fit with Diabetes, has the more help with your patients who need exercise. Exercising with Complications: Eyes and Kidneys This is a good one to print out add to your handouts.

The stem cells that make the beta-cells May Not Exist!

Risky Brazil Experiment Enables Type I Diabetics to Live Without Insulin, Other Medicines

A peptide developed by scientists at Weill Cornell Medical College may expand the availability and durability of islet cell transplant for patients with type-1 diabetes.